本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Trevi Therapeutics Inc.

10.56
+0.02500.24%
成交量:61.07萬
成交額:646.58萬
市值:12.85億
市盈率:-25.40
高:10.82
開:10.40
低:10.30
收:10.53
52周最高:11.11
52周最低:2.36
股本:1.22億
流通股本:9,063.42萬
量比:0.52
換手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):-0.4155
每股收益(LYR):-0.4698
淨資產收益率:-35.74%
總資產收益率:-22.83%
市淨率:6.48
市盈率(LYR):-22.46

資料載入中...

2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/04/14

重要事件披露

8-K - Current report
2023/04/11

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report